摘要
目的:验证万拉法新治疗广泛性焦虑的疗效及不良反应。方法:68例广泛性焦虑症按就医顺序分为两组,分别用万拉法新及阿普唑仑进行治疗,疗程6周,于治疗前及治疗后第1、2、4、6周末进行汉密顿焦虑量表(HAMA)、焦虑自评量表(SAS)、副反应量表(TESS)评定疗效及不良反应。结果:万拉法新和阿普唑仑两药疗效相仿,万拉法新不良反应少而轻微。结论:万拉法新是治疗广泛性焦虑症较为理想的药物。
Objective ：To verify the clinical efficacy and the side effects of venlafaxine in the treatment of general anxiety disorder. Methods：68 patients were assigned to velafaxine group and alprazolam group respectively for 6 weeks. The efficacy and side effects were evaluated by HAMA, SAS and TESS before and after 1,2,3,4 and 6 weeks. Results： The efficacy of venlafaxine and al- prazolam had no significant difference, but venlafaxine had fewer side effects. Conclusions： Venlafaxine is an effective and safe medicine in the treatment of general anxiety disorder.
出处
《中国民康医学》
2006年第11期455-456,共2页
Medical Journal of Chinese People’s Health
